These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16973621)

  • 21. NEK5 interacts with topoisomerase IIβ and is involved in the DNA damage response induced by etoposide.
    Melo-Hanchuk TD; Slepicka PF; Pelegrini AL; Menck CFM; Kobarg J
    J Cell Biochem; 2019 Oct; 120(10):16853-16866. PubMed ID: 31090963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of the anti-neoplastic drug doxorubicin on XPD-mutated DNA repair-deficient human cells.
    Saffi J; Agnoletto MH; Guecheva TN; Batista LF; Carvalho H; Henriques JA; Stary A; Menck CF; Sarasin A
    DNA Repair (Amst); 2010 Jan; 9(1):40-7. PubMed ID: 19926538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of Topoisomerase IIβ in DNA Damage Response following IR and Etoposide.
    Sunter NJ; Cowell IG; Willmore E; Watters GP; Austin CA
    J Nucleic Acids; 2010 Aug; 2010():. PubMed ID: 20847952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SCF
    Shu J; Cui D; Ma Y; Xiong X; Sun Y; Zhao Y
    Oncogenesis; 2020 Feb; 9(2):8. PubMed ID: 32015321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered stability of etoposide-induced topoisomerase II-DNA complexes in resistant human leukaemia K562 cells.
    Ritke MK; Roberts D; Allan WP; Raymond J; Bergoltz VV; Yalowich JC
    Br J Cancer; 1994 Apr; 69(4):687-97. PubMed ID: 8142256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The retinoblastoma tumor suppressor protein is required for efficient processing and repair of trapped topoisomerase II-DNA-cleavable complexes.
    Xiao H; Goodrich DW
    Oncogene; 2005 Dec; 24(55):8105-13. PubMed ID: 16091739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Role of DNA Topoisomerase Binding Protein 1 (TopBP1) in Genome Stability in
    Parra-Nunez P; Cooper C; Sanchez-Moran E
    Plants (Basel); 2021 Nov; 10(12):. PubMed ID: 34961037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of DNA topoisomerase IIbeta in neurite outgrowth.
    Nur-E-Kamal A; Meiners S; Ahmed I; Azarova A; Lin CP; Lyu YL; Liu LF
    Brain Res; 2007 Jun; 1154():50-60. PubMed ID: 17493591
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The polyphenolic ellagitannin vescalagin acts as a preferential catalytic inhibitor of the α isoform of human DNA topoisomerase II.
    Auzanneau C; Montaudon D; Jacquet R; Puyo S; Pouységu L; Deffieux D; Elkaoukabi-Chaibi A; De Giorgi F; Ichas F; Quideau S; Pourquier P
    Mol Pharmacol; 2012 Jul; 82(1):134-41. PubMed ID: 22528119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alternative RNA Processing of Topoisomerase IIα in Etoposide-Resistant Human Leukemia K562 Cells: Intron Retention Results in a Novel C-Terminal Truncated 90-kDa Isoform.
    Kanagasabai R; Serdar L; Karmahapatra S; Kientz CA; Ellis J; Ritke MK; Elton TS; Yalowich JC
    J Pharmacol Exp Ther; 2017 Jan; 360(1):152-163. PubMed ID: 27974648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The efficacy of topoisomerase II-targeted anticancer agents reflects the persistence of drug-induced cleavage complexes in cells.
    Bandele OJ; Osheroff N
    Biochemistry; 2008 Nov; 47(45):11900-8. PubMed ID: 18922022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism of repair of 5'-topoisomerase II-DNA adducts by mammalian tyrosyl-DNA phosphodiesterase 2.
    Schellenberg MJ; Appel CD; Adhikari S; Robertson PD; Ramsden DA; Williams RS
    Nat Struct Mol Biol; 2012 Dec; 19(12):1363-71. PubMed ID: 23104055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Replicative helicases can translocate through abasic site-induced covalent topoisomerase IV-DNA complexes.
    Shea ME; Hiasa H
    Nucleic Acids Res; 2001 Feb; 29(3):614-21. PubMed ID: 11160881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PP2A-B56ϵ complex is involved in dephosphorylation of γ-H2AX in the repair process of CPT-induced DNA double-strand breaks.
    Li X; Nan A; Xiao Y; Chen Y; Lai Y
    Toxicology; 2015 May; 331():57-65. PubMed ID: 25772433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Various inhibitors of DNA topoisomerases diminish repair-specific DNA incision in UV-irradiated human fibroblasts.
    Thielmann HW; Popanda O; Gersbach H; Gilberg F
    Carcinogenesis; 1993 Nov; 14(11):2341-51. PubMed ID: 8242865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypersensitivity of nonhomologous DNA end-joining mutants to VP-16 and ICRF-193: implications for the repair of topoisomerase II-mediated DNA damage.
    Adachi N; Suzuki H; Iiizumi S; Koyama H
    J Biol Chem; 2003 Sep; 278(38):35897-902. PubMed ID: 12842886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The catalytic topoisomerase II inhibitor dexrazoxane induces DNA breaks, ATF3 and the DNA damage response in cancer cells.
    Deng S; Yan T; Nikolova T; Fuhrmann D; Nemecek A; Gödtel-Armbrust U; Kaina B; Wojnowski L
    Br J Pharmacol; 2015 May; 172(9):2246-57. PubMed ID: 25521189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell cycle activation in postmitotic neurons is essential for DNA repair.
    Schwartz EI; Smilenov LB; Price MA; Osredkar T; Baker RA; Ghosh S; Shi FD; Vollmer TL; Lencinas A; Stearns DM; Gorospe M; Kruman II
    Cell Cycle; 2007 Feb; 6(3):318-29. PubMed ID: 17297309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chinese hamster ovary cells resistant to the topoisomerase II catalytic inhibitor ICRF-159: a Tyr49Phe mutation confers high-level resistance to bisdioxopiperazines.
    Sehested M; Wessel I; Jensen LH; Holm B; Oliveri RS; Kenwrick S; Creighton AM; Nitiss JL; Jensen PB
    Cancer Res; 1998 Apr; 58(7):1460-8. PubMed ID: 9537249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel small molecule hybrid of vorinostat and DACA displays anticancer activity against human hormone-refractory metastatic prostate cancer through dual inhibition of histone deacetylase and topoisomerase I.
    Yu CC; Pan SL; Chao SW; Liu SP; Hsu JL; Yang YC; Li TK; Huang WJ; Guh JH
    Biochem Pharmacol; 2014 Aug; 90(3):320-30. PubMed ID: 24915421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.